NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 886 coverANTICANCER MOLECULES: STRUCTURE, FUNCTION, AND DESIGN Copyright © 1999 by the New York Academy of Sciences
description

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by NIKITIN, A. YU.
Articles by LEE, W.-H.
Search for Related Content
PubMed
PubMed Citation
Articles by NIKITIN, A. YU.
Articles by LEE, W.-H.
Annals of the New York Academy of Sciences 886:12-22 (1999)
© 1999 New York Academy of Sciences

A Paradigm for Cancer Treatment Using the Retinoblastoma Gene in a Mouse Model

ALEXANDER YU. NIKITINa, DANIEL J. RILEYb AND WEN-HWA LEEa,c

aDepartment of Molecular Medicine/Institute of Biotechnology, The University of Texas Health Science Center, San Antonio, Texas 78245-3207, USA
bDepartment of Medicine, The University of Texas Health Science Center, San Antonio, Texas 78245-3207, USA

cTo whom requests for reprints should be addressed: Institute of Biotechnology, The University of Texas Health Science Center, 15355 Lambda Drive, San Antonio, Texas 78245-3207. Phone, 210/567-7351; fax, 210/567-7377.
e-mail, leew{at}uthscsa.edu

Discovery of tumor suppressor genes has provided a rational approach to cancer prevention and treatment. Loss of retinoblastoma susceptibility gene (Rb) function is a rate-limiting event in the development of human and mouse cancers. Establishment of animal models of cancer associated with Rb deficiency allowed us to develop and test long-awaited approaches to genetic correction for treating tumors in vivo. Recent studies demonstrated that (1) prevention of carcinogenesis is achieved by correction of gene copy number in Rb+/- mice, and (2) reconstitution of Rb gene functions is sufficient for suppression of neoplasia in immunocompetent mice. These results fulfill a promise of cancer treatment by reconstitution of tumor suppressor function.




This article has been cited by other articles:


Home page
Cancer Res.Home page
A. Yu. Nikitin, A. Alcaraz, M. R. Anver, R. T. Bronson, R. D. Cardiff, D. Dixon, A. E. Fraire, E. W. Gabrielson, W. T. Gunning, D. C. Haines, et al.
Classification of Proliferative Pulmonary Lesions of the Mouse: Recommendations of the Mouse Models of Human Cancers Consortium
Cancer Res., April 1, 2004; 64(7): 2307 - 2316.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Yu. Nikitin, B. Shan, A. Flesken-Nikitin, K.-H. Chang, and W.-H. Lee
The Retinoblastoma Gene Regulates Somatic Growth during Mouse Development
Cancer Res., April 1, 2001; 61(7): 3110 - 3118.
[Abstract] [Full Text]



footerLeft footerRight